Literature DB >> 10720939

Understanding hypertension through genetic manipulation in mice.

B Cvetkovic1, C D Sigmund.   

Abstract

With the advances in mouse molecular genetics and physiology during the last decade, the mouse has become the animal model of choice for studying the genetic basis of many diseases. Terms such as "transgenic" and "knockout" have become part of a colloquial language used in most research laboratories that are investigating human diseases. These terms refer to the two most commonly used methods for analyzing the function of a gene in vivo: overexpression (transgenic mouse) and deletion (knockout mouse). Both methods have proved to be extremely useful in establishing the importance of specific genes in genetic disorders, such as hypertension. The choice of genes being investigated in relationship to hypertension was governed by the knowledge of systems regulating vascular and renal physiology. Thus, it is not surprising that most of the focus was given to the renin-angiotensin system (RAS). Apart from the RAS, other systems known to regulate vascular tone and/or electrolyte and fluid homeostasis have also been analyzed using transgenic and knockout approaches. This review briefly summarizes some of the mouse models relevant to renal mechanisms of hypertension and then discusses the future of genetic manipulation in mice for studying the genetics of hypertension.

Entities:  

Mesh:

Year:  2000        PMID: 10720939     DOI: 10.1046/j.1523-1755.2000.057003863.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

Review 1.  The role of 20-HETE in androgen-mediated hypertension.

Authors:  Cheng-Chia Wu; Michal Laniado Schwartzman
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-06-22       Impact factor: 3.072

2.  A genetically clamped renin transgene for the induction of hypertension.

Authors:  Kathleen M I Caron; Leighton R James; Hyung-Suk Kim; Scott G Morham; Maria Luisa S Sequeira Lopez; R Ariel Gomez; Timothy L Reudelhuber; Oliver Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

Review 3.  Dopamine receptor-coupling defect in hypertension.

Authors:  Pedro A Jose; Gilbert M Eisner; Robin A Felder
Journal:  Curr Hypertens Rep       Date:  2002-06       Impact factor: 5.369

Review 4.  Vascular actions of 20-HETE.

Authors:  Samantha L Hoopes; Victor Garcia; Matthew L Edin; Michal L Schwartzman; Darryl C Zeldin
Journal:  Prostaglandins Other Lipid Mediat       Date:  2015-03-23       Impact factor: 3.072

5.  Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model.

Authors:  Asada Leelahavanichkul; Qin Yan; Xuzhen Hu; Christoph Eisner; Yuning Huang; Richard Chen; Diane Mizel; Hua Zhou; Elizabeth C Wright; Jeffrey B Kopp; Jürgen Schnermann; Peter S T Yuen; Robert A Star
Journal:  Kidney Int       Date:  2010-08-25       Impact factor: 10.612

6.  Androgen-induced hypertension in angiotensinogen deficient mice: role of 20-HETE and EETS.

Authors:  Victor Garcia; Jennifer Cheng; Adam Weidenhammer; Yan Ding; Cheng-Chia Wu; Fan Zhang; Katherine Gotlinger; John R Falck; Michal L Schwartzman
Journal:  Prostaglandins Other Lipid Mediat       Date:  2014-12-17       Impact factor: 3.072

7.  Phenotype analysis of mice deficient in the peptide transporter PEPT2 in response to alterations in dietary protein intake.

Authors:  Isabelle M Frey; Isabel Rubio-Aliaga; Martina Klempt; Eckhard Wolf; Hannelore Daniel
Journal:  Pflugers Arch       Date:  2006-04-04       Impact factor: 3.657

Review 8.  20-HETE and blood pressure regulation: clinical implications.

Authors:  Cheng-Chia Wu; Tanush Gupta; Victor Garcia; Yan Ding; Michal L Schwartzman
Journal:  Cardiol Rev       Date:  2014 Jan-Feb       Impact factor: 2.644

Review 9.  Adrenomedullin in vascular diseases.

Authors:  Katsuyuki Ando; Tatsuo Shimosawa; Toshiro Fujita
Journal:  Curr Hypertens Rep       Date:  2004-02       Impact factor: 5.369

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.